Complement Is Essential for Protection by an IgM and an IgG3 Monoclonal Antibody Against Experimental, Hematogenously Disseminated Candidiasis
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The incidence of life-threatening, hematogenously disseminated candidiasis, which is predominantly caused by Candida albicans, parallels the use of modern medical procedures that adversely affect the immune system. Limited antifungal drug choices and emergence of drug-resistant C. albicans strains indicate the need for novel prevention and therapeutic strategies. We are developing vaccines and Abs that enhance resistance against experimental candidiasis. However, the prevalence of serum anti-Candida Abs in candidiasis patients has led to the misconception that Abs are not protective. To explain the apparent discrepancy between such clinical observations and our work, we compared functional activities of C. albicans-specific protective and nonprotective mAbs. Both kinds of Abs are agglutinins that fix complement and are specific for cell surface mannan, but the protective Abs recognize β-mannan, and the nonprotective Ab is specific for α-mannan. By several indirect and direct measures, the protective mAbs more efficiently bind complement factor C3 to the yeast cell than do nonprotective Ab. We hypothesize that the C3 deposition causes preferential association of blood-borne fungi with host phagocytic cells that are capable of killing the fungus. We conclude from these results that the protective potential of Abs is dependent on epitope specificity, serum titer, and ability to rapidly and efficiently fix complement to the fungal surface. The mechanism of protection appears to be associated with enhanced phagocytosis and killing of the fungus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Epidemiology of nosocomial fungal infections
Fridkin, S. K., & Jarvis, W. R. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.499 · Cited by 782
Wessels, M. R., Butko, P., Ma, M., Warren, H. B., Lage, A. L., & Carroll, M. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11490 · Cited by 503 · cited 1×
“Female mice deficient in complement component C3 (C3 2/2 mice) were obtained by homologous recombination in embryonic stem cells as previously described (37).”
MethodSelf-citationNosocomial Candidemia: Risk Factors and Attributable Mortality
Wenzel, R. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1531 · Cited by 502
Qian, Q., Jutila, M. A., Van Rooijen, N., & Cutler, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5000 · Cited by 246
Self-citationActivation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast
Kozel, T. R., & Pfrommer, G. S. (1986) · Infection and Immunity · doi:10.1128/iai.52.1.1-5.1986 · Cited by 102
Self-citationPfaller, M. A., Lockhart, S. R., Pujol, C., Swails-Wenger, J. A., Messer, S. A., Edmond, M. B., Jones, R. N., Wenzel, R. P., & Soll, D. R. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.6.1518-1529.1998 · Cited by 91
Cited by
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
Romani, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1255 · Cited by 758
The immune response to fungal infections
Shoham, S., & Levitz, S. M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05397.x · Cited by 392
“It has been observed that the protective potential of antibodies with enhanced phagocytosis and killing of the fungus is dependent upon epitope specificity, serum titre, and ability to rapidly and efficiently fix complement to the fungal surface (Han et al, 2001).”
BackgroundIoan-Facsinay, A., de Kimpe, S. J., Hellwig, S. M. M., van Lent, P. L., Hofhuis, F. M. A., van Ojik, H. H., Sedlik, C., da Silveira, S. A., Gerber, J., de Jong, Y. F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00294-7 · Cited by 304
Moore, G. L., Chen, H., Karki, S., & Lazar, G. A. (2010) · mAbs · doi:10.4161/mabs.2.2.11158 · Cited by 266
Determinants of Candidemia and Candidemia-Related Death in Cardiothoracic ICU Patients
Michalopoulos, A. S., Geroulanos, S., & Mentzelopoulos, S. D. (2003) · Chest · doi:10.1378/chest.124.6.2244 · Cited by 121
Animal models in the analysis of Candida host–pathogen interactions
de Repentigny, L. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.06.001 · Cited by 69
Utilization of ferroproteins byCandida albicans during candidastasis by apotransferrin
Han, Y. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02973884 · Cited by 14
Self-citationCandida albicans can utilize siderophore during candidastasis caused by apotransferrin
Lee, J.-H., & Han, Y. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02969401 · Cited by 11
Self-citation
Metadata
- Authors
- Han, Y., Kozel, T. R., Zhang, M. X., MacGill, R. S., Carroll, M. C., & Cutler, J. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-08-01
- Volume
- 167
- Issue
- 3
- Pages
- 1550-1557
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2114158362
- Cited by
- 143
- References
- 7
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.